1401O Trastuzumab deruxtecan (T-DXd) monotherapy and combinations in patients (pts) with advanced/metastatic HER2-positive (HER2+) esophageal, gastric or gastroesophageal junction adenocarcinoma (GEJA): DESTINY-Gastric03 (DG-03)
医学
曲妥珠单抗
胃食管交界处
食管腺癌
内科学
肿瘤科
腺癌
胃肠病学
癌症
乳腺癌
作者
Y. Y. Janjigian,Hanneke W.M. van Laarhoven,Sun Young Rha,V S Kozlov,D-Y. Oh,A. Gravina,L. Rapatoni,H. Shoji,R.D. Hofheinz,L-T. Chen,Hugo Ford,Maxime Chénard-Poirier,Saeed Raoufmoghaddam,C. Lloyd,Chi Zhang,C. Mateo,Jae Man Lee